ABSTRACT
Objectives To investigate the association between childhood adversity and COVID-19-related hospitalization and COVID-19-related mortality in the UK Biobank.
Design Cohort study.
Setting United Kingdom.
Participants 151,200 participants in the UK Biobank cohort who had completed the Childhood Trauma Screen, were alive at the start of the COVID-19 pandemic (01-10-2021), and were still active in the UK Biobank when hospitalization and mortality data were most recently updated (11-2021).
Main outcome measures COVID-19-related hospitalization and COVID-19-related mortality.
Results Higher self-reports of childhood adversity were related to greater likelihood of COVID-19-related hospitalization in all statistical models. In models adjusted for age, ethnicity, and sex, childhood adversity was associated with an OR of 1.228 of hospitalization (95% CI=1.155 to 1.31, Childhood Adversity z=6.51, p<0.005) and an OR of 1.25 of a COVID-19 related death (95% CI=1.11 to 1.425, Childhood Adversity z=3.53, p<0.005). Adjustment for potential confounds attenuated these associations, although associations remained statistically significant.
Conclusions Childhood adversity was significantly associated with COVID-19-related hospitalization and COVID-19-related mortality after adjusting for sociodemographic and health confounders. Further research is needed to clarify the biological and psychosocial processes underlying these associations to inform public health intervention and prevention strategies to minimize COVID-19 disparities.
Trial registration Work Completed under UK Biobank Project ID 92699 (“Associations between COVID-19 Symptoms & Stressful Life Experiences”).
What is already known on this topic
Disparities in COVID-19 outcomes are driven by numerous health and sociodemographic risk factors
Childhood adversity is associated with lifelong physical health disparities and early mortality
No known studies to date have examined the association between childhood adversity and COVID-19 mortality and morbidity
What the study adds
In the UK Biobank, childhood adversity was significantly associated with COVID-19-related hospitalization and COVID-19-related mortality.
For both morbidity and mortality, these links were seen in statistical models adjusted for important sociodemographic and physical health confounders.
How this study might affect research, practice or policy
Modifiable and more proximal psychosocial factors may impact adult health outcomes, including COVID-19-related mortality and hospitalization
Adversity may relate to depression, self-concept, or self-regulation, cascading from childhood experiences to the outcomes that we investigated here.
Pinpointing these processes may allow for policy and interventions to lessen the negative impact of COVID-19 in those that have suffered childhood adversity.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institutional Review Board at the University of Pittsburgh has approved of this work, under protocol STUDY22080014. The Institutional Review Board determined that the proposed activity is not research involving human subjects as defined by DHHS and FDA regulations, given that it was using secondary research with previously collected, de-identified data.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Declarations: The corresponding author attests that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted.
Competing interests: All authors have completed the ICMJE uniform disclosure form at http://www.icmje.org/disclosure-of-interest/ and declare: no support from any organization for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.
Funding: This work was funded by internal grants provided to Dr. Hanson by the University of Pittsburgh.
We updated our models using a revised coding of race/ethnicity. We also included a manuscript supplement to detail some sensitivity models.
Data Availability
All data are available from the UB Biobank. This resource is available to scientists from the UK and outside, whether they work in the public or private sector, for industry, academia or a charity, subject to verification that the research is health-related and in the public interest.
